Open AccessClinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
Author(s) -
Jinfei Si,
Xiaodong Gu,
Wenxian Wang,
Shenpeng Ying,
Zhengbo Song
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-2828
Subject(s) - medicine , t790m , epidermal growth factor receptor , lung cancer , adenocarcinoma , oncology , mutation , tyrosine kinase , cancer research , gefitinib , cancer , receptor , gene , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom